Biotech & Drug Discovery
Stable3.9% of YC companies (-0.19pp)
Companies
230
Survival Rate
89.6%
Hiring Rate
16.1%
Recent Pivots
12
Biotech & Drug Discovery — Share of YC companies over time
Pivots into Biotech & Drug Discovery
Companies that pivoted into this category
Zenbase AI
S243 people · Active
Continuous prompt optimization for LLMs from DSPy core contributors
100x faster scientific evidence synthesis
Kingdom Supercultures
S2018 people · Active
New foods with microbes
Natural functional ingredients that actually work
Anthrogen
S246 people · Active· Pivot 2/2
We make molecules like fuels and plastics from the air.
We're training the next generation of protein foundation models.
Flair Health
S232 people · Active· Pivot 1/2
Platform to reduce care gaps for patients with inflammatory disease
Platform to address the unique challenges of specialty medication…
Pivots out of Biotech & Drug Discovery
Companies that pivoted away from this category
Medium Biosciences
S216 people · Active
AI-designed Protein Therapeutics
AI-designed Affinity Reagents
Louiza Labs
S252 people · Active
Simulated human biology and synthetic medical datasets.
Digital Twins
Event Horizon Labs
W241 people · Active
SciPhi is building R2R, the most advanced retrieval system.
We are building the Post-Human Trader.
Cairns Health
S1717 people · Active
Koko Labs makes the most effective cure for insomnia
Your voice. Your health. We care.
Splendor
W221 people · Active· Pivot 1/2
Maximizing your child's potential through genetic screening.
Splendor helps nonprofits find and win grants.
Pivots within Biotech & Drug Discovery
Companies that changed direction but stayed in this category
Bramante
Sp252 people · Active
American drug manufacturing
Life sciences instrument and reagent manufacturing
Origin
W264 people · Active
AI for safer cell & gene therapies
AI and Data for Cell & Gene therapies
iollo
S224 people · Active
At-home metabolomics test for healthy lifespan extension
AI platform accelerating therapeutic R&D from years to days.
Companies (230)
10x Science
The AI-native platform for next-generation protein characterization.
Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs